Tectonic Therapeutic, Inc.
TECX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $16,927 | $17,185 | $13,036 | $9,156 |
| G&A Expenses | $4,963 | $5,147 | $5,262 | $4,835 |
| SG&A Expenses | $4,963 | $5,147 | $5,262 | $4,835 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21,890 | $22,332 | $18,298 | $13,991 |
| Operating Income | -$21,890 | -$22,332 | -$18,298 | -$13,991 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2,855 | $3,324 | $2,392 | $1,618 |
| Pre-Tax Income | -$19,035 | -$19,008 | -$15,906 | -$12,373 |
| Tax Expense | $0 | $976 | $0 | $0 |
| Net Income | -$19,035 | -$19,984 | -$15,906 | -$12,373 |
| % Margin | – | – | – | – |
| EPS | -1.02 | -1.07 | -0.93 | -0.84 |
| % Growth | 4.7% | -15.1% | -10.7% | – |
| EPS Diluted | -1.02 | -1.07 | -0.93 | -0.84 |
| Weighted Avg Shares Out | 18,713 | 18,680 | 17,158 | 14,793 |
| Weighted Avg Shares Out Dil | 18,713 | 18,680 | 17,158 | 14,793 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,900 | $3,389 | $2,444 | $1,735 |
| Interest Expense | $14 | $17 | $20 | $22 |
| Depreciation & Amortization | $0 | $340 | $360 | $508 |
| EBITDA | -$19,021 | -$18,651 | -$15,526 | -$11,843 |
| % Margin | – | – | – | – |